Literature DB >> 1550667

White coat hypertension diagnosed by 24-h ambulatory monitoring. Examination of 159 newly diagnosed hypertensive patients.

A Høegholm1, K S Kristensen, N H Madsen, T L Svendsen.   

Abstract

The study was conducted to estimate the frequency of white coat hypertension, ie, hypertension when in contact with the doctor only, in patients with newly diagnosed hypertension. We studied 159 consecutive patients (median age 47 years, 86 women) referred from primary health care to a hypertension clinic. For all patients, their general practitioner had decided to treat the hypertension pharmacologically, but the treatment had not yet begun. The blood pressure measurements reported from the referring doctors were 164.1 +/- 18.1/104.3 +/- 7.1 mm Hg (mean +/- SD). Measured at the hypertension clinic with random zero sphygmomanometer the pressures were 156.8 +/- 22.5/99.8 +/- 11.7 mm Hg. The indirectly measured day-time ambulatory blood pressures were 145.2 +/- 18.1/95.9 +/- 11.5 mm Hg. When a cut-off level of 90 mm Hg diastolic was applied, all patients were considered hypertensive by the referring doctors' measurements; the random zero office measurements regarded 18.3% of the patients as normotensive. The ambulatory measurements regarded a further 24.8% as normotensive (white coat hypertensive), whereas five patients considered normotensive by office measurements were hypertensive when evaluated by ambulatory monitoring (reverse white coat phenomenon). The difference between systolic office measurements and the daytime ambulatory blood pressures was significantly larger for female patients; age was positively correlated and weight negatively correlated to this difference. No significant difference was found for the diastolic measurements. It is concluded that white coat hypertension is present in approximately a quarter of the patients with newly diagnosed hypertension. By implementing ambulatory monitoring in clinical practice some of the overdiagnosing will possibly be avoided, but further studies on the subject are needed.

Entities:  

Mesh:

Year:  1992        PMID: 1550667     DOI: 10.1093/ajh/5.2.64

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  9 in total

Review 1.  Masked hypertension: a common but insidious presentation of hypertension.

Authors:  D W McKay; Martin G Myers; Peter Bolli; Arun Chockalingam
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

Review 2.  Ambulatory blood pressure improves prediction of cardiovascular risk: implications for better antihypertensive management.

Authors:  Lawrence R Krakoff
Journal:  Curr Atheroscler Rep       Date:  2013-04       Impact factor: 5.113

Review 3.  Defining the patient group for cost-effective withdrawal of antihypertensive therapy.

Authors:  L R Krakoff; S Wassertheil-Smoller
Journal:  Pharmacoeconomics       Date:  1995-03       Impact factor: 4.981

Review 4.  Diagnosis and management of patients with white-coat and masked hypertension.

Authors:  Giuseppe Mancia; Michele Bombelli; Gino Seravalle; Guido Grassi
Journal:  Nat Rev Cardiol       Date:  2011-08-09       Impact factor: 32.419

5.  Preventing misdiagnosis of ambulatory hypertension: algorithm using office and home blood pressures.

Authors:  Daichi Shimbo; Sujith Kuruvilla; Donald Haas; Thomas G Pickering; Joseph E Schwartz; William Gerin
Journal:  J Hypertens       Date:  2009-09       Impact factor: 4.844

Review 6.  Clinical uses of ambulatory blood pressure monitoring.

Authors:  R J Portman; R J Yetman
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

7.  Comparing the effects of white coat hypertension and sustained hypertension on mortality in a UK primary care setting.

Authors:  Martin G Dawes; Gillian Bartlett; Andrew J Coats; Edmund Juszczak
Journal:  Ann Fam Med       Date:  2008 Sep-Oct       Impact factor: 5.166

8.  Validation of self reported diagnosis of hypertension in a cohort of university graduates in Spain.

Authors:  Alvaro Alonso; Juan José Beunza; Miguel Delgado-Rodríguez; Miguel Angel Martínez-González
Journal:  BMC Public Health       Date:  2005-09-12       Impact factor: 3.295

9.  The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome.

Authors:  Silvia Vidali; Sepideh Aminzadeh-Gohari; René Günther Feichtinger; Renaud Vatrinet; Andreas Koller; Felix Locker; Tricia Rutherford; Maura O'Donnell; Andrea Stöger-Kleiber; Bridget Lambert; Thomas Klaus Felder; Wolfgang Sperl; Barbara Kofler
Journal:  Oncotarget       Date:  2017-07-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.